Oxidant-redox regulation of pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling

Cardiology in Review

Volumn 18, Issue 2, 2010, Pages 89-93

  Wolin, Michael S ^a   Gupte, Sachin A ^b   Neo, Boon Hwa ^a   Gao, Qun ^a   Ahmad, Mansoor ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Hypoxia; Nitric oxide; Pulmonary hypertension; Redox signaling

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC GMP; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GUANYLATE CYCLASE; HEME; HYDROGEN PEROXIDE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; THIOL;

HYPOXIC LUNG VASOCONSTRICTION; LUNG ARTERY; MUSCLE FUNCTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PULMONARY ARTERY; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ANOXIA; CYCLIC GMP; CYTOSOL; DISEASE PROGRESSION; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION, PULMONARY; NADP; NITRIC OXIDE; OXIDANTS; OXIDATION-REDUCTION; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATION;

EID: 77149168173     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181c9f088     Document Type: Review

References (45)

1. 2 responses in calf pulmonary resistance arteries. Am J Physiol. 1992;262:L560-L565.
2. Michelakis ED, Hampl V, Nsair A, et al. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res. 2002;90:1307-1315.
3. Le Cras TD, McMurtry IF. Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol. 2001;280:L575-L582.
4. Coggins MP, Bloch KD. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol. 2007;27:1877-1885.
5. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev. 2008;88:1009-1086.
6. Gupte SA, Wolin MS. Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. Am J Physiol Heart Circ Physiol. 2006;290:H2228-H2238.
7. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol. 2005;98:390-403.
8. Waypa GB, Schumacker PT. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol. 2005;98:404-414.
9. Wolin MS, Ahmad M, Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol. 2005;289:L159-L173.
10. Archer SL, Will JA, Weir EK. Redox status in the control of pulmonary vascular tone. Herz. 1986;11:127-141.
11. 2 sensor in rat pulmonary vasculature. Circ Res. 1993;73:1100-1112.
12. Wolin MS. Reactive oxygen species and the control of vascular function. Am J Physiol Heart Circ Physiol. 2009;296:H539-H549.
13. 2 sensor in the pulmonary artery. J Appl Physiol. 1989;66:167-170.
14. 2 and cGMP. Am J Physiol. 1993;264:L141-L145.
15. 2-elicited responses. Am J Physiol. 1995;269:L637-L644.
16. Gupte SA, Kaminski PM, Floyd B, et al. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol. 2005; 288:H13-H21.
17. Gupte SA, Arshad M, Viola S, et al. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am J Physiol Heart Circ Physiol. 2003;285:H2316-H2326.
18. Gao Q, Wolin MS. Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2008;295:H978-H989.
19. 2 production via NADH-derived superoxide. Am J Physiol. 1996;270:H1044-H1053.
20. 2. Am J Physiol. 1999;276:H235-H241.
21. Ahmad M, Zhao X, Kelly MR, et al. Heme oxygenase-1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD. Am J Physiol Heart Circ Physiol. 2009;297:H1453-H1461.
22. Ahmad M, Kaminski PM, Wolin MS. Modulation of the contractile response of bovine pulmonary arteries to hypoxia by plumbagin, an inhibitor of Nox oxidase-4. FASEB J. 2007;21:A922.
23. Ahmad M, Kelly MR, Kandhi S, et al. Nox-4 siRNA causes attenuation of hypoxic pulmonary vasoconstriction in bovine pulmonary arteries. FASEB J. 2009;23:1002-1008.
24. Ahmad M, Zhao X, Kelly MR, et al. TGF β-1 mediated increase in Nox-4 expression enhances hypoxic pulmonary vasoconstriction in bovine pulmonary arteries. FASEB J. 2008;22:1152.22.
25. Wolin MS, Ahmad M, Gao Q, et al. Cytosolic NAD(P)H regulation of redox signaling and vascular oxygen sensing. Antioxid Redox Signal. 2007;9:671-678.
26. Gupte SA, Okada T, McMurtry IF, et al. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction. Pulm Pharmacol Ther. 2006;19:303-309.
27. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol. 1987;252:H721-H732.
28. Lincoln TM, Dey N, Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol. 2001;91:1421-1430.
29. Burgoyne JR, Madhani M, Cuello F, et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science. 2007;317:1393-1397.
30. Neo BH, Kandhi S, Wolin MS. Potential role of a thiol oxidation-elicited subunit dimerization activation of protein kinase G in the relaxation of pulmonary arteries to hydrogen peroxide. FASEB J. 2009;23:1002-1006.
31. Mingone CJ, Gupte SA, Ali N, et al. Thiol oxidation inhibits nitric oxide-mediated pulmonary artery relaxation and guanylate cyclase stimulation. Am J Physiol Lung Cell Mol Physiol. 2006;290:L549-L557.
32. Stasch JP, Schmidt PM, Nedvetsky PI, et al. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest. 2006;116:2552-2561.
33. Gupte SA, Rupawalla T, Phillibert D Jr, et al. NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO. Am J Physiol. 1999;277:L1124-L1132.
34. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60:79-127.
35. Mingone CJ, Ahmad M, Gupte SA, et al. Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide. Am J Physiol Heart Circ Physiol. 2008; 294:H1244-H1250.
36. Turkseven S, Kruger A, Mingone CJ, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H701-H707.
37. Mingone CJ, Gupte SA, Chow JL, et al. Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. Am J Physiol Lung Cell Mol Physiol. 2006;291: L337-L344.
38. Wolin MS, Wood KS, Ignarro LJ. Guanylate cyclase from bovine lung: A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. J Biol Chem. 1982;257:13312-13320.
39. Dumitrascu R, Weissmann N, Ghofrani HA, et al. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation. 2006;113:286-295.
40. Schermuly RT, Stasch JP, Pullamsetti SS, et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J. 2008;32:881-891.
41. Huang J, Kaminski PM, Edwards JG, et al. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline- induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1250-L1259.
42. Gupte SA, Wolin MS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal. 2008;10:1137-1152.
43. Wilkins MR, Wharton J, Grimminger F, et al. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J. 2008;32:198-209.
44. Ghofrani HA, Grimminger F. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy. Eur Respir Rev. 2009; 18:35-41.
45. Schafer S, Ellinghaus P, Janssen W, et al. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodeling. Cardiovasc Res. 2009;82:30-39.